Multicentric reference values for some quantities measured with Tina-Quant reagents systems and RD/Hitachi analysers

Establishing accurate reference values is essential for interpreting diagnostic test results. Prior research has shown that reference intervals can vary based on population characteristics and measurement techniques. No prior work had resolved how to standardize these values across multiple clinical settings. This gap motivated a collaborative effort to generate unified reference limits. The study focused on specific biomarkers like ferritin and transferrin. These markers are commonly used in clinical settings to assess iron metabolism and inflammation. However, discrepancies in reference ranges across laboratories remain a challenge. This paper's contribution is to address that variability through a multicenter approach.

The aim of this study was to produce standardized reference values for selected biomarkers using Tina-Quant reagents and RD/Hitachi analysers. The specific problem addressed was the lack of consistent reference limits across clinical laboratories. This work was driven by the need for harmonized diagnostic interpretation. The study involved ten clinical centers in Spain. These centers collaborated to collect data from reference individuals. The goal was to blend results from multiple sites to create a unified reference framework. The study also aimed to model a cooperative approach between industry and clinical labs. This collaboration was intended to improve the accuracy and comparability of diagnostic results.

The study involved ten clinical laboratories across Spain. Each lab collected data from reference individuals for specific analytes. The analytes included ferritin, transferrin, and rheumatoid factors. C-reactive protein and antistreptolysin O were also included in the analysis. The Tina-Quant reagents and RD/Hitachi analysers were used for measurements. Roche Diagnostics España provided logistical and technical support. Reference limits were calculated using a centralized data-blending approach. The methods followed the guidelines of the International Federation of Clinical Chemistry.

The study produced multicenter reference limits for five biomarkers. These limits were derived from a pooled dataset across ten clinical labs. Ferritin reference ranges were established with specific upper and lower bounds. Transferrin levels showed consistent patterns across the participating centers. Rheumatoid factor measurements followed similar standardized ranges. C-reactive protein reference values were harmonized across the dataset. Antistreptolysin O levels were also standardized using this collaborative approach. The results demonstrated the feasibility of a multicenter reference value production model.

The authors propose that this study provides a model for collaborative reference value production. The findings suggest that harmonized reference limits can be achieved through multi-lab cooperation. The study supports the use of Tina-Quant reagents and RD/Hitachi analysers for this purpose. The authors emphasize the importance of industry-lab partnerships in diagnostic standardization. The results align with the recommendations of the International Federation of Clinical Chemistry. The authors suggest that this approach can be extended to other biomarkers. The study does not claim to resolve all diagnostic variability issues. The authors propose that further work may build on this collaborative framework.